))
NSCLC METex14 Skipping
Manage episode 450345478 series 3599769
Content provided by Ontada Learn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ontada Learn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of OncoTalks, Dr. David Waterhouse and Dr. Paul Conkling discuss NSCLC and the groundbreaking developments in treating patients with MET exon 14 (METex14) skipping mutations. We review the science behind these targeted therapies, their clinical applications, and the impact on patient outcomes.
13 episodes
Share
